{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T05:22:34Z","timestamp":1734758554249,"version":"3.32.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1993,1,1]],"date-time":"1993-01-01T00:00:00Z","timestamp":725846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1993]]},"DOI":"10.1007\/bf00686018","type":"journal-article","created":{"date-parts":[[2004,11,29]],"date-time":"2004-11-29T09:15:45Z","timestamp":1101719745000},"page":"25-30","source":"Crossref","is-referenced-by-count":12,"title":["Methimazole as a protectant against cisplatin-induced nephrotoxicity using the dog as a model"],"prefix":"10.1007","volume":"33","author":[{"given":"David M.","family":"Vail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan A.","family":"Elfarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. James","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David L.","family":"Panciera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Gregory","family":"MacEwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve A.","family":"Soergel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1136\/bmj.2.5652.290","volume":"2","author":"WD Alexander","year":"1969","unstructured":"Alexander WD, Evans V, Macaulay A, Gallagher TF, Londono J (1969) Metabolism of35S-labelled antithyroid drugs in man. BMJ 2: 290","journal-title":"BMJ"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1096\/fasebj.4.14.2227215","volume":"4","author":"ME Anderson","year":"1990","unstructured":"Anderson ME, Naganuma A, Meister A (1990) Protection against cisplatin toxicity by administration of glutothione ester. FASEB J 4: 3251","journal-title":"FASEB J"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0163-7258(89)90114-9","volume":"41","author":"RF Borch","year":"1989","unstructured":"Borch RF, Markman M (1989) Biochemical modulation of cisplatin toxicity. Pharmacol Ther 41: 371","journal-title":"Pharmacol Ther"},{"key":"CR4","first-page":"345","volume":"52","author":"RS Brodey","year":"1979","unstructured":"Brodey RS (1979) The use of naturally occurring cancer in domestic animals for research into human cancer: general considerations and a review of canine skeletal osteosarcoma. Yale J Biol Med 52: 345","journal-title":"Yale J Biol Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0006-3002(60)91579-1","volume":"44","author":"WD Brown","year":"1960","unstructured":"Brown WD (1960) Reduction of protein disulfide bonds by sodium borohydride. Biochim Biophys Acta 44: 365","journal-title":"Biochim Biophys Acta"},{"key":"CR6","first-page":"55","volume":"33","author":"RR Cavalieri","year":"1981","unstructured":"Cavalieri RR, Pitt-Rivers R (1981) The effects of drugs on the distribution and metabolism of thyroid hormones. Pharmacol Rev 33: 55","journal-title":"Pharmacol Rev"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/1097-0142(197704)39:4<1357::AID-CNCR2820390402>3.0.CO;2-C","volume":"39","author":"E Cvitkovic","year":"1977","unstructured":"Cvitkovic E, Spualding J, Bethune V, Martin J, Whitmore WF (1977) Improvement ofcis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cancer 39: 1357","journal-title":"Cancer"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/0003-9861(84)90206-6","volume":"235","author":"D DiMonte","year":"1984","unstructured":"DiMonte D, Ross D, Bellomo G, Eklow L, Orrenius S (1984) Alerations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes. Arch Biochem Biophys 235: 334","journal-title":"Arch Biochem Biophys"},{"key":"CR9","first-page":"551","volume":"213","author":"DC Dobyan","year":"1980","unstructured":"Dobyan DC, Levi J, Jacobs J, Kosek J, Wiener MW (1980) Mechanisms ofcis-platinum nephrotoxicity. II. Morphological observations. J Pharmacol Exp Ther 213: 551","journal-title":"J Pharmacol Exp Ther"},{"key":"CR10","first-page":"387","volume-title":"Toxicology of the kidney","author":"AA Elfarra","year":"1993","unstructured":"Elfarra AA (1993) Aliphatic halogenated hydrocarbons. In: Hook JB, Goldstein R (eds) Toxicology of the kidney. Raven, New York, pp 387?413"},{"key":"CR11","first-page":"69","volume":"134","author":"MJ Fregly","year":"1961","unstructured":"Fregly MJ (1961) Increased water exchange in rats treated with antithyroid drugs. J Pharmacol Exp Ther 134: 69","journal-title":"J Pharmacol Exp Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2460\/ajvr.1991.52.11.1821","volume":"52","author":"EM Hardie","year":"1991","unstructured":"Hardie EM, Page RL, Williams PL, Fischer WD (1991) Effect of time of cisplatin administration on its toxicity and pharmacokinetics in dogs. Am J Vet Res 52: 1821","journal-title":"Am J Vet Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0300-483X(88)90143-6","volume":"51","author":"J Hannemann","year":"1988","unstructured":"Hannemann J, Bauman K (1988) Cisplatin-induced lipid peroxidation and decreased gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers. Toxicology 51: 119","journal-title":"Toxicology"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2460\/javma.1991.199.08.1057","volume":"199","author":"SA Kraigel","year":"1991","unstructured":"Kraigel SA, Madewell BR, Simonson E, Gregory CR (1991) Osteogenic sarcoma and cisplatin chemotherapy in dogs: 16 cases (1986?1989). J Am Vet Med Assoc 199: 1057","journal-title":"J Am Vet Med Assoc"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0034-5288(91)90119-9","volume":"50","author":"MA Labato","year":"1991","unstructured":"Labato MA, Ross LA (1991) Plasma disappearance of creatinine as a renal function test in the dog. Res Vet Sci 50: 253","journal-title":"Res Vet Sci"},{"key":"CR16","first-page":"1734","volume":"195","author":"SM Larue","year":"1989","unstructured":"Larue SM, Withrow SJ, Powers BE, Wrigley RH, Gillette EL, Schwarz PD, Straw RC, Richter SL (1989) Limb-sparing treatment for osteosarcoma in dogs. J Am Vet Med Assoc 195: 1734","journal-title":"J Am Vet Med Assoc"},{"key":"CR17","first-page":"169","volume":"7","author":"C Litterst","year":"1977","unstructured":"Litterst C, Torres IJ, Guarino AM (1977) Plasma levels and organ distribution of platinum in the rat, dog, and dogfish shark following single intravenous administration ofcis-dichlorodiammineplatinum(II). J Clin Hematol Oncol 7: 169","journal-title":"J Clin Hematol Oncol"},{"key":"CR18","first-page":"1355","volume-title":"The kidney, vol. 2","author":"JF Maher","year":"1976","unstructured":"Maher JF (1976) Toxic nephropathy. In: Brenner BM, Rector FC (eds) The kidney, vol. 2. W. B. Saunders, Philadelphia, p 1355"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/0006-2952(90)90121-Z","volume":"39","author":"TJ Montine","year":"1990","unstructured":"Montine TJ, Borch RF (1990) Role of endogenous sulfur-containing nucleophiles in an in vitro model ofcis-diamminedichloroplatinum(II)-induced nephrotoxicity. Biochem Pharmacol 39: 1751","journal-title":"Biochem Pharmacol"},{"key":"CR20","first-page":"1076","volume":"49","author":"GK Ogilvie","year":"1988","unstructured":"Ogilvie GK, Krawiec DR, Gelberg HB, Twardock AR, Reschke RW, Richardson BC (1988) Evaluation of a short-term saline diuresis protocol for the administration of cisplatin. Am J Vet Res 49: 1076","journal-title":"Am J Vet Res"},{"key":"CR21","first-page":"1399","volume":"195","author":"GK Ogilvie","year":"1989","unstructured":"Ogilvie GK, Moore AS, Curtis CR (1989) Evaluation of cisplatin-induced emesis in dogs with malignant neoplasia: 115 cases (1984?1987). J Am Vet Med Assoc 195: 1399","journal-title":"J Am Vet Med Assoc"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2460\/javma.1991.199.05.613","volume":"199","author":"GK Ogilvie","year":"1991","unstructured":"Ogilvie GK, Straw RC, Powers BE, Cooper MF, Withrow SJ (1991) Prevalence of nephrotoxicity associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987?1989). J Am Vet Med Assoc 199: 613","journal-title":"J Am Vet Med Assoc"},{"key":"CR23","first-page":"349","volume":"56","author":"DL Panciera","year":"1992","unstructured":"Panciera DL, Post K (1992) Effect of oral administration of sulfadiazine and trimethoprin in combination on thyroid function in dogs. Can J Vet Res 56: 349","journal-title":"Can J Vet Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1939-1676.1988.tb02812.x","volume":"2","author":"ME Peterson","year":"1988","unstructured":"Peterson ME, Kintzer PP, Hurvitz AI (1988) Methimazole treatment of 262 cats with hyperthyroidism. J Vet Intern Med 2: 150","journal-title":"J Vet Intern Med"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1210\/jcem-33-2-182","volume":"33","author":"JA Pittman","year":"1971","unstructured":"Pittman JA, Beschi RJ, Smitherman TC (1971) Methimazole: its absorption and excretion in man and tissue distribution in rats. J Clin Endocrinol Metab 33: 182","journal-title":"J Clin Endocrinol Metab"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/jnci\/80.18.1486","volume":"80","author":"R Quazi","year":"1988","unstructured":"Quazi R, Chang AYC, Borch RF, Montine T, Dedon P, Olughner J, Bennett JM (1988) Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin. J Natl Cancer Inst 80: 1486","journal-title":"J Natl Cancer Inst"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev.pa.30.040190.003131","volume":"30","author":"DJ Reed","year":"1990","unstructured":"Reed DJ (1990) Glutathione: toxicological implications. Annu Rev Pharmacol Toxicol 30: 603","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"6139","DOI":"10.1016\/S0021-9258(19)39303-2","volume":"265","author":"PJ Sausen","year":"1990","unstructured":"Sausen PJ, Elfarra AA (1990) Cysteine conjugate S-oxidase: characterization of a novel enzymatic activity in rat hepatic and renal microsomes. J Biol Chem 265: 6139","journal-title":"J Biol Chem"},{"key":"CR29","first-page":"393","volume":"260","author":"PJ Sausen","year":"1992","unstructured":"Sausen PJ, Elfarra AA, Cooley AJ (1992) Methimazole protection of rats against chemically induced kidney damage in vivo. J Pharmacol Exp Ther 260: 393","journal-title":"J Pharmacol Exp Ther"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0041-008X(73)80009-2","volume":"25","author":"U Schaeppi","year":"1973","unstructured":"Schaeppi U, Heyman IA, Fleischman RW, Rosenkrantz H, Ilievski V, Phelan R, Cooney DA, Davis RD (1973)cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice. Toxicol Appl Pharmacol 25: 230","journal-title":"Toxicol Appl Pharmacol"},{"key":"CR31","first-page":"507","volume":"192","author":"W Shapiro","year":"1988","unstructured":"Shapiro W, Fossum TW, Kitchell BE, Couto CG, Theilen GH (1988) Use of cisplatin for treatment of appendicular osteosarcoma in dogs. J Am Vet Med Assoc 192: 507","journal-title":"J Am Vet Med Assoc"},{"key":"CR32","first-page":"432","volume":"184","author":"DS Sitar","year":"1973","unstructured":"Sitar DS, Thornhill DP (1973) Methimazole: absorption, metabolism, and excretion in the albino rat. J Pharmacol Exp Ther 184: 432","journal-title":"J Pharmacol Exp Ther"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/00498257309151507","volume":"3","author":"GG Skellern","year":"1973","unstructured":"Skellern GG, Stenlake JB, Williams WD (1973) The absorption, distribution, excretion and metabolism of2?14C-methimazole in rat. Xenobiotica 3: 121","journal-title":"Xenobiotica"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2885.1991.tb00850.x","volume":"14","author":"LA Trepanier","year":"1991","unstructured":"Trepanier LA, Peterson ME, Aucoin DP (1991) Pharmacokinetics of intravenous and oral methimazole following single and multiple dose administration in normal cats. J Vet Pharmacol Ther 14: 367","journal-title":"J Vet Pharmacol Ther"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-2952(89)90233-5","volume":"38","author":"BM Tune","year":"1989","unstructured":"Tune BM, Fravert D, Hsu CY (1989) Oxidative and mitochondrial toxic effects of cephalosporin antibiotics in the kidney. Biochem Pharmacol 38: 795","journal-title":"Biochem Pharmacol"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00003086-199109000-00023","volume":"270","author":"SJ Withrow","year":"1991","unstructured":"Withrow SJ, Powers BE, Straw RC, Wilkins RM (1991) Comparative aspects of osteosarcoma: dog versus man. Clin Orthop 270: 159","journal-title":"Clin Orthop"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0009-2797(89)90065-3","volume":"70","author":"F Zunino","year":"1989","unstructured":"Zunino F, Pratesi G, Micheloni A, Cavalletti E, Sala F, Tofanetti O (1989) Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the antitumor drug. Chem-Biol Interact 70: 89","journal-title":"Chem-Biol Interact"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686018.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00686018\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00686018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T20:39:44Z","timestamp":1734727184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00686018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1993]]}},"alternative-id":["BF00686018"],"URL":"https:\/\/doi.org\/10.1007\/bf00686018","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[1993]]}}}